Air Force

Combined cholesterol and bilirubin tests as risk predictors for coronary artery disease

  • US Patent No. 6869802
  • Issued: March 22, 2005
  • Status: Expired
Medical & Biotechnology

A new method for predicting the risk of coronary artery disease (CAD) is disclosed. The method uses a ratio made up of the levels of an individuals LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C) and serum total bilirubin (bilirubin). The ratio, using a weighted value for bilirubin, is LDL-C/(HDL-C+bilirubin).

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us